key: cord-0927277-n38uxkx6 authors: Shokri, Somayeh; Mahmoudvand, Shahab; Taherkhani, Reza; Farshadpour, Fatemeh title: Modulation of the immune response by Middle East respiratory syndrome coronavirus date: 2018-08-26 journal: J Cell Physiol DOI: 10.1002/jcp.27155 sha: 5bfd9a40e27ada726f348a238e9509989780aedf doc_id: 927277 cord_uid: n38uxkx6 Coronavirus (CoV) infections are commonly associated with respiratory and enteric disease in humans and animals. In 2012, a new human disease called Middle East respiratory syndrome (MERS) emerged in the Middle East. MERS was caused by a virus that was originally called human coronavirus‐Erasmus Medical Center/2012 but was later renamed as Middle East respiratory syndrome coronavirus (MERS‐CoV). MERS‐CoV causes high fever, cough, acute respiratory tract infection, and multiorgan dysfunction that may eventually lead to the death of the infected individuals. The exact origin of MERS‐CoV remains unknown, but the transmission pattern and evidence from virological studies suggest that dromedary camels are the major reservoir host, from which human infections may sporadically occur through the zoonotic transmission. Human to human transmission also occurs in healthcare facilities and communities. Recent studies on Middle Eastern respiratory continue to highlight the need for further understanding the virus‐host interactions that govern disease severity and infection outcome. In this review, we have highlighted the major mechanisms of immune evasion strategies of MERS‐CoV. We have demonstrated that M, 4a, 4b proteins and Plppro of MERS‐CoV inhibit the type I interferon (IFN) and nuclear factor‐κB signaling pathways and therefore facilitate innate immune evasion. In addition, nonstructural protein 4a (NSP4a), NSP4b, and NSP15 inhibit double‐stranded RNA sensors. Therefore, the mentioned proteins limit early induction of IFN and cause rapid apoptosis of macrophages. MERS‐CoV strongly inhibits the activation of T cells with downregulation of antigen presentation. In addition, uncontrolled secretion of interferon ɣ‐induced protein 10 and monocyte chemoattractant protein‐1 can suppress proliferation of human myeloid progenitor cells. During summer of 2012, in Jeddah, Saudi Arabia, a novel coronavirus (CoV; Middle East respiratory syndrome coronavirus [MERS-CoV]) was isolated from the sputum of a patient with acute pneumonia and renal failure (de Groot et al., 2013) concentrations of viral RNA can also be found in stool, urine, and blood samples . and is most phylogenetically related to two bat coronaviruses, Tylonycteris bat coronavirus HKU4 (Ty-BatCoV HKU4) and Pipistrellus bat coronavirus HKU5 (Pi-BatCoV HKU5), providing insight on its evolutionary origin Zumla, Hui, & Perlman, 2015) . Table 1 shows the amino acid (aa) sequences identities between HKU4, HKU5, and MERS-CoV (Corman et al., 2014) . The genome structure is a polycistronic positive-sense singlestranded RNA with~30 kb in size and encoding 20 proteins. The 5' end of the genome contains two open reading frames (ORFs), ORF1a and ORF1b, which encode two polyproteins (pp), pp1a and pp1ab; production of pp1ab requires a ribosomal frameshift to transcribe the portion encoded by ORF1b. ORF1a encodes viral proteases, main protease (M pro , also called 3CL pro ), and papain-like protease (PL pro ), which are responsible for cleavage of the ORF1a and ORF1b. These polyproteins are further cleaved into 16 nonstructural proteins, whereas the 3′ end of the viral genome encodes four structural proteins (E, N, S, and M; Mustafa, Balkhy, & Gabere, 2017) . Upon infection, these proteins are expressed to facilitate viral replication and propagation in the host (Cho, Lin, Chuang, & Hsu, 2016; Durai, Batool, Shah, & Choi, 2015) . Each coronavirus has a specific group of genes, which is responsible for encoding accessory proteins (Y. Yang et al., 2013) . These accessory proteins do not participate in the structure of MERS-CoV particles but have an essential role in viral replication and evasion of the host immune response (de Haan, Masters, Shen, Weiss, & Rottier, 2002; Haijema, Volders, & Rottier, 2004; D. X. Liu, Fung, Chong, Shukla, & Hilgenfeld, 2014; Matthews, Coleman, van der Meer, Snijder, & Frieman, 2014; Niemeyer et al., 2013) . They are difficult to study because of their low expression level as well as their low molecular weight. In addition, they are not conserved in the coronavirus subfamilies. Although the accessory proteins can be targeted by antiviral therapeutics, the biological function of these proteins is still not well understood. MERS-CoV has five accessory proteins: 3, 4a, 4b, 5, and 8b, encoded by various ORFs (Durai et al., 2015) . Figure 1 provides details on the organization of the MERS-CoV genome. A functional receptor of MERS-CoV is dipeptidyl peptidase 4 (DPP4) from both human and bat . DPP4, a 766-aalong type-II transmembrane glycoprotein, is mainly expressed on epithelial cells and controls the activity of hormones and chemokines Chan, Lau, & Woo, 2013; Zhang, Jiang, & Du, 2014) . This receptor binds to a 231 residue region in the spike (S) protein of MERS-CoV, a domain different from the receptorbinding site of other Betacoronaviruses. The S protein and the receptor-binding site within this protein induce neutralizing antibodies and, in principle, could serve as a subunit vaccine (Lu et al., 2013; Mou et al., 2013) . Small molecules or peptides that prevent the binding of DPP4 are potential MERS-CoV entry inhibitors, and a few (Alcami & Koszinowski, 2000) . Here, we provide an overview of the different mechanisms that MERS-CoV use to evade host immune responses. The immune system is canonically divided into two major branches, innate and adaptive immunity. The innate response elicited by an invading pathogen involves the rapid recognition of general molecular patterns by nonimmune cells or cells of the innate immune system, such as monocytes or macrophages, dendritic cells, and natural killer cells (Nicholson, 2016) . Hence, the first barrier to overcome for successful viral infection is the rapid innate immune response of the host, which are involved in several effector mechanisms, including complement cascade, type I Interferons (IFNs), inflammatory cytokine, NK cell immunity, apoptosis, autophagy, and toll-like receptors (TLRs) pathway. When the innate immune system confronts a pathogen, it becomes activated and prepares the adaptive arm of the immune system to respond appropriately (Takeuchi & Akira, 2009 ). Viral infection of mammalian cells prompts the innate immune system to mount the first line of defense (Takeuchi & Akira, 2009 ). Type I IFNs (mainly IFN-α and IFN-β) are major effector cytokines in innate antiviral response (González-Navajas, Lee, David, & Raz, 2012) . These IFNs activate the JAK-STAT pathway to stimulate the expression of interferon-stimulated genes (ISGs), which collectively inhibit viral F I G U R E 1 Genome organization of the MERS-CoV is illustrated by boxes in this genome scheme. The genome contains two large 5′-proximal ORFs (ORF1a and 1b) that encode two replicase polyproteins, whose mature products assemble into the viral replication and transcription complex. The 3′ end of the genome encodes structural and accessory proteins. The 3, 4a, 4b, 5, and 8b accessory proteins are located between the structural proteins S and E, whereas 8b resides downstream of the N protein. replication and assembly. The genes encoding IFNs are regulated by the assembly of an enhanceosome containing several transcription factors including nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3), both of which are regulated by subcellular localization (Seth, Sun, Ea, & Chen, 2005) . In tissue cells, transcription of the IFN-β gene represents the primary response to virus infection (Haagmans et al., 2004) . Induction of the IFN-β gene requires the constitutively expressed transcription factor IRF3. IRF3 is the key transcription factor for IFN-β, ISG56, interferon ɣ-induced protein 10 (IP-10), and other antiviral genes (Hiscott, 2007) . In uninfected cells, IRF-3 is inactive and resides in the cytoplasm but transported to the nucleus. Upon infection, IRF-3 is phosphorylated and dimerized before it enters the nucleus to upregulate IFN-α and IFN-β gene transcription, where it recruits the transcriptional coactivator cAMP-response element binding protein and p300 to initiate IFN-β mRNA synthesis (Fitzgerald et al., 2003; Suhara, Yoneyama, Kitabayashi, & Fujita, 2002) . Upon virus infection, to induce IFN production, pathogen- leading to reduced activation of IRF3 . TRAF3 functions as an adapter that bridges the mitochondrial transducer MAVS with the downstream signaling complex containing TBK1 and IKK-ɛ kinases that are essential for IRF3 activation (Guo & Cheng, 2007) . SARS-CoV M protein also prevents the formation of TRAF3·TANK·TBK1/IKK-ɛ complex leading to reduced IRF3 activation and thereby inhibits IFN production (Siu et al., 2009 RNA-binding protein has no effect on the activity of downstream effectors such as RIG-I, MDA5, MAVS, TBK1, and IRF3 (Siu, Yeung et al., 2014) . Protein 4a is 109 aa long and contains an RNA-binding domain comprising 72 aa. The RNA-binding domain of 4a binds dsRNA and does not allow it to bind to the RNA-binding domain of RIG-I, thereby inhibiting the antiviral signaling pathway. Thus, the virus blocks the innate immune response and continues infecting cells. The two key residues involved in the binding of RNA to the RNA-binding domain in 4a are K63 and K67 (Siu, Yeung et al., 2014) . ORF4a is the most potent antagonist, because can inhibit multiple levels of the IFN response via the inhibition of both IFN production (IFN-β promoter activity, IRF-3 and NF-κB activation) and the ISRE promoter element signaling pathway (Y. Yang et al., 2013) . ORF4b encodes an accessory protein of MERS-CoV. NSP4b proteins with 246aa are multifunctional with activities in both the cytoplasm and nucleus, consistent with its localization in both cellular compartments. ORF4b protein is unlikely to be a potent inhibitor of the NF-κB signalling pathway (Matthews et al., 2014) . Coronaviruses encode multifunctional enzymes with protease activity (PL pro ). These enzymes are necessary for deubiquitinating (DUB)/ deISGylating activity and processing the viral replicase polyproteins (Mielech, Kilianski, Baez-Santos, Mesecar, & Baker, 2014) . The ubiquitin pathway is important for regulating a number of innate immune pathways, and the ability of a viral protein to cleave ubiquitin from host cell proteins can contribute to virus pathogenesis. In addition to ubiquitination, modification of cellular proteins with ISG15 is known to have a broad spectrum antiviral activity. ISG15 is the ubiquitin-like protein that can be conjugated to cellular targets via a mechanism called ISGylation, regulating innate immune responses. Coronavirus PLPs are known to have the ability to remove ISG15 conjugates from cellular substrates and reduces the levels of ubiquitinated and ISGylated host cell proteins (Clementz et al., 2010) . MERS-CoV PL pro acts as a potential IFN antagonist by interfering with the IRF3 and NF-kB (X. Yang et al., 2014) . NSP15 is an endoribonuclease. The mechanism by which NSP15 endoribonuclease activity suppresses the activation of dsRNA sensors is unknown. Deng et al. (2017) reported that macrophages infected with the NSP15 mutant virus had a significant dispersal of dsRNA as compared to the cells infected with wild-type virus, where the majority of dsRNA has been accompanied by replication complexes. Figure 3 shows the MERS-CoV escape from the dsRNA sensors. In infection of MERS-CoV, T cells play critical roles in controlling the pathogenesis (J. Zhao et al., 2014) . Furthermore, T cells from human peripheral blood mononuclear cells, human lymphoid tissues, and the F I G U R E 3 Activation of dsRNA sensors results in an early induction of interferon, rapid apoptosis of macrophages and a protective immune response. NSP4a limits the activation of PKR, thereby rescuing translation inhibition. NSP4b inhibits RNase L activity. Limitation of RNase L activation leads to decreased IFN production in cells. dsRNA: double-stranded RNA; NSP: nonstructural protein; PKR: protein kinase R; OAS: oligoadenylate synthetase [Color figure can be viewed at wileyonlinelibrary.com] spleen of common marmosets were highly susceptible to MERS-CoV. MERS-CoV induces substantial apoptosis in the infected T cells that involve the activation of the intrinsic and extrinsic caspasedependent apoptosis pathways, resulting in high pathogenicity of the virus . and failure to present virus antigen to T cells Zhou et al., 2014) . Downregulation of antigen presentation pathways (decreased MHC I and II, costimulatory molecules) in macrophages and dendritic cells during MERS-CoV infection would strongly inhibit the activation of T cells. (Faure et al., 2014; Josset et al., 2013) . The clinical course of MERS in patients shows that secretion of monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 10 also known as IP-10 and interleukin 10 is uncontrolled (Kim et al., 2016; Ying, Li, & Dimitrov, 2016) . IP-10 and MCP-1 can suppress proliferation of human myeloid progenitor cells (Broxmeyer et al., 1993) . The induction of these chemokines may inevitably aggravate the lymphopenia in patients with MERS . The relationship between a virus and its host is a complicated affair: a Reliable vaccines have not yet been developed but antivirals inhibiting virus replication, such as mycophenolic acid, cyclosporine A, IFN-α, IFN-β, or ribavirin are available. The attenuated viruses generated might prove useful in vaccine development. Reverse genetics system is a tool to study the molecular biology of the virus, understanding novel gene functions, high-throughput screening of antiviral drugs, and to develop attenuated viruses as vaccine candidates. Using this system a collection of MERS-CoV deletion mutants has been generated. If deletion of genes that causing the virus to escape from the immune system presented growth kinetics similar to those of the wild-type virus, indicating which is helpful to prevent MERS-CoV infection. The authors declare that there are no conflicts of interest. Fatemeh Farshadpour http://orcid.org/0000-0002-8317-9573 Middle East respiratory syndrome coronavirus (MERS-CoV): A perpetual challenge Viral mechanisms of immune evasion Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate The middle east respiratory syndrome coronavirus respiratory infection: An emerging infection from the Arabian Peninsula, The Microbiology of Respiratory System Infections Spiking the MERScoronavirus receptor Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression The emerging novel Middle East respiratory syndrome coronavirus: The "knowns" and "unknowns" Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea Macro domain from Middle East respiratory syndrome coronavirus (MERS-CoV) is an efficient ADP-ribose binding module crystal structure and biochemical studies Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages Clinical features and virological of Middle East respiratory syndrome coronavirus infection. The Lancet Infectious Diseases Middle East respiratory syndrome coronavirus: Transmission, virology and therapeutic targeting to aid in outbreak control Distinct immune response in two MERS-CoVinfected patients: Can we go from bench to bedside? Evasion of host innate immunity by emerging viruses: Antagonizing host RIG-I pathways IKKε and TBK1 are essential components of the IRF3 signaling pathway Immunomodulatory functions of type I interferons Cytosolic sensing of viruses Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the coronavirus study group Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis Triggering the innate antiviral response through IRF-3 activation Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with Human coronavirus-HKU1 infection among adults in Cleveland Nuclear factor-κB in cancer development and progression RIG-I-like receptors: Cytoplasmic sensors for non-self RNA Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection To sense or not to sense viral RNA-Essentials of coronavirus innate immune evasion The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: Implications for the origin of the novel Middle East respiratory syndrome coronavirus Immune evasion by Kaposi's sarcoma-associated herpesvirus Accessory proteins of SARS-CoV and other coronaviruses NF-κB signaling in inflammation Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3 The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling MERS-CoV papain-like protease has deISGylating and deubiquitinating activities The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review A structural analysis of M protein in coronavirus assembly and morphology The immune system Middle East respiratory syndrome coronavirus accessory protein 4a Is a Type I interferon antagonist Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody Middle East respiratory syndrome coronavirus (MERS-CoV)-Saudi Arabia, Geneva: WHO. Accessed 21 Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3 Immune evasion by viruses. eLS Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3·TANK·TBK1/IKKϵ Complex Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I Innate immunity to virus infection Middle East respiratory syndrome coronavirus NS4b protein inhibits host RNase L activation SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon Functional classification of interferon-stimulated genes identified using microarrays Viral immune evasion: A masterpiece of evolution A molecular arms race between host innate antiviral response and emerging human coronaviruses Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papainlike protease The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists Discovery of T-cell infection and apoptosis by Middle East respiratory syndrome coronavirus The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Current advancements and potential strategies in the development of MERS-CoV vaccines Rapid generation of a mouse model for Middle East respiratory syndrome Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis Middle East respiratory syndrome Modulation of the immune response by Middle East respiratory syndrome coronavirus